247 related articles for article (PubMed ID: 9799987)
21. Distortion product otoacoustic emissions and outer hair cell defects in the hyt/hyt mutant mouse.
Li D; Henley CM; O'Malley BW
Hear Res; 1999 Dec; 138(1-2):65-72. PubMed ID: 10575115
[TBL] [Abstract][Full Text] [Related]
22. Age-related decline of auditory function in the chinchilla (Chinchilla laniger).
McFadden SL; Campo P; Quaranta N; Henderson D
Hear Res; 1997 Sep; 111(1-2):114-26. PubMed ID: 9307317
[TBL] [Abstract][Full Text] [Related]
23. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of distortion product otoacoustic emissions in noise-exposed chinchillas.
Davis B; Qiu W; Hamernik RP
J Am Acad Audiol; 2005 Feb; 16(2):69-78. PubMed ID: 15807046
[TBL] [Abstract][Full Text] [Related]
25. Differential responses to acoustic damage and furosemide in auditory brainstem and otoacoustic emission measures.
Mills DM
J Acoust Soc Am; 2003 Feb; 113(2):914-24. PubMed ID: 12597185
[TBL] [Abstract][Full Text] [Related]
26. Magnitude changes in transient evoked otoacoustic emissions and high-level 2f1-f2 distortion products in man during quinine administration.
Berninger E; Karlsson KK; Hellgren U; Eskilsson G
Scand Audiol; 1995; 24(1):27-32. PubMed ID: 7761795
[TBL] [Abstract][Full Text] [Related]
27. Distortion product otoacoustic emission and auditory brain stem response measures of pediatric sensorineural hearing loss with islands of normal sensitivity.
Balfour PB; Pillion JP; Gaskin AE
Ear Hear; 1998 Dec; 19(6):463-72. PubMed ID: 9867294
[TBL] [Abstract][Full Text] [Related]
28. [Transitory evoked and distortion products of otoacoustic emissions in absent auditory evoked potentials].
Schöler C; Schönweiler R; Ptok M
HNO; 1997 Dec; 45(12):1008-15. PubMed ID: 9486382
[TBL] [Abstract][Full Text] [Related]
29. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
Moulin A
J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
[TBL] [Abstract][Full Text] [Related]
30. [Objective audiometry with DPOAEs : New findings for generation mechanisms and clinical applications. German version].
Zelle D; Dalhoff E; Gummer AW
HNO; 2016 Nov; 64(11):822-830. PubMed ID: 27761597
[TBL] [Abstract][Full Text] [Related]
31. Evoked-potential thresholds and cubic distortion product otoacoustic emissions in the chinchilla following carboplatin treatment and noise exposure.
Jock BM; Hamernik RP; Aldrich LG; Ahroon WA; Petriello KL; Johnson AR
Hear Res; 1996 Jul; 96(1-2):179-90. PubMed ID: 8817317
[TBL] [Abstract][Full Text] [Related]
32. Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C.
Casale M; Mazzarelli C; Vespasiani Gentilucci U; Potena M; Pappacena M; Faiella F; Galati G; Salvinelli F; Picardi A
Int J Immunopathol Pharmacol; 2012; 25(2):551-6. PubMed ID: 22697091
[TBL] [Abstract][Full Text] [Related]
33. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
Norton SJ; Gorga MP; Widen JE; Folsom RC; Sininger Y; Cone-Wesson B; Vohr BR; Mascher K; Fletcher K
Ear Hear; 2000 Oct; 21(5):508-28. PubMed ID: 11059707
[TBL] [Abstract][Full Text] [Related]
34. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
Janssen T; Niedermeyer HP; Arnold W
ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
[TBL] [Abstract][Full Text] [Related]
35. High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions.
Arnold DJ; Lonsbury-Martin BL; Martin GK
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):215-22. PubMed ID: 10037289
[TBL] [Abstract][Full Text] [Related]
36. Effect of Successive Administration of Vancomycin and Amikacin on Auditory Function of Immature Animals.
D'yakonova IN; Kamkina OV; Rakhmanova IV; Ishanova YS; Burmistrova DS
Bull Exp Biol Med; 2017 Feb; 162(4):458-461. PubMed ID: 28243909
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Mitoquinone for Protecting Against Amikacin-Induced Ototoxicity in Guinea Pigs.
Dirain CO; Ng MRAV; Milne-Davies B; Joseph JK; Antonelli PJ
Otol Neurotol; 2018 Jan; 39(1):111-118. PubMed ID: 29194212
[TBL] [Abstract][Full Text] [Related]
38. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
Mills DM
Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
[TBL] [Abstract][Full Text] [Related]
39. Physiological effects of auditory nerve myelinopathy in chinchillas.
El-Badry MM; Ding DL; McFadden SL; Eddins AC
Eur J Neurosci; 2007 Mar; 25(5):1437-46. PubMed ID: 17425569
[TBL] [Abstract][Full Text] [Related]
40. CD1 hearing-impaired mice. I: Distortion product otoacoustic emission levels, cochlear function and morphology.
Le Calvez S; Avan P; Gilain L; Romand R
Hear Res; 1998 Jun; 120(1-2):37-50. PubMed ID: 9667429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
